—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Amneal Pharmaceuticals, Inc. Class A Common Stock（AMRX）— 同業公司組

數據截至2026-10-07 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。

Amneal Pharmaceuticals, Inc. Class A Common Stock的Closelook綜合評分為55/100，在同業公司組內排名第6位（共11家）——組內評分最高的是DexCom Inc（66/100）。

名稱綜合動能品質估值訊號距52週高點
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock55895843ok7.2%
ROVI.MC Laboratorios Farmaceuticos ROVI62277853info30.8%
ALM.MC Almirall S.A.53224669warn25.6%
FAGR.BR Fagron NV53485760info9.7%
APTX.TO Apotex Health Corp47355951——
RDY Dr. Reddy’s Laboratories Ltd ADR46294463info20.9%
SFZN.SW Siegfried Holding Ltd42284555info31.8%
DXCM DexCom Inc66838138bear9.9%
ONC BeiGene, Ltd.64816532ok5.5%
MEDP Medpace Holdings Inc63817530ok10.9%
PTGX Protagonist Therapeutics Inc60776212info12.4%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-07

Quick answers

Amneal Pharmaceuticals, Inc. Class A Common Stock在Closelook涵蓋範圍內的同業公司有哪些？

分組首先根據共同的Closelook指數成分，其次根據產業：Laboratorios Farmaceuticos ROVI (ROVI.MC)、Almirall S.A. (ALM.MC)、Fagron NV (FAGR.BR)、Apotex Health Corp (APTX.TO)、Dr. Reddy’s Laboratories Ltd ADR (RDY)、Siegfried Holding Ltd (SFZN.SW)、DexCom Inc (DXCM)、BeiGene, Ltd. (ONC)等。

AMRX相對同業公司的評分如何？

Amneal Pharmaceuticals, Inc. Class A Common Stock的綜合評分為55/100，組內排名第6位（共11家），截至2026-10-07；組內最高綜合評分為DexCom Inc（66/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.